Table 2.
Baseline and change in baseline measures
| Clinical measure | Negative qPCR, mean (±SD) | Positive qPCR, mean (±SD) | p value* for mean difference |
|---|---|---|---|
| Baseline UUIE per day | 4.72 (±2.86) | 5.71 (±2.60) | 0.0045 |
| Baseline OABq SF symptom severity | 70.86 (±18.03) | 67.33 (±19.38) | 0.34 |
| Change in UUIE per daya | −3.79 (±2.81) | −4.35 (±2.80) | 0.12 |
| Change in OABq SF symptom severity | −45.39 (±25.12) | −44.69 (±22.43) | 0.88 |
UUIE urgency urinary incontinence episodes, OABq SF overactive Bladder Questionnaire Short Form, qPCR quantitative polymerase chain reaction
*
p value based on the Wilcoxon rank-sum test
a
Measured as mean change from baseline over months 1 through 6